المؤلفون: John P. A. Ioannidis, Hannah Ewald, Juan Martin-Liberal, Andreas M. Schmitt, Lars G. Hemkens, Benjamin Kasenda, Arnav Agarwal, Amanda K. Herbrand, Thomas Schmid, Florian Naudet, Matthias Briel, Heiner C. Bucher, Aviv Ladanie, Tiago da Veiga Pereira, Benjamin Speich, Francesco Sclafani

المساهمون: University Hospital Basel [Basel], University of Oxford [Oxford], Centre d'Investigation Clinique [Rennes] (CIC), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), University of Toronto, McMaster University [Hamilton, Ontario], University of Leicester, Institut Jules Bordet [Bruxelles], Faculté de Médecine [Bruxelles] (ULB), Université libre de Bruxelles (ULB)-Université libre de Bruxelles (ULB), St. Clara Hospital [Basel], Stanford University, University of Oxford, Université de Rennes (UR)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), Jonchère, Laurent

المصدر: JAMA Network Open
JAMA Network Open, American Medical Association, 2020, 3 (11), pp.e2024406. ⟨10.1001/jamanetworkopen.2020.24406⟩
JAMA Network Open, 2020, 3 (11), pp.e2024406. ⟨10.1001/jamanetworkopen.2020.24406⟩

مصطلحات موضوعية: medicine.medical_specialty, [SDV]Life Sciences [q-bio], Comparative effectiveness research, Antineoplastic Agents, Disease-Free Survival, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, Interquartile range, law, Neoplasms, Internal medicine, Biomarkers, Tumor, medicine, Humans, 030212 general & internal medicine, Drug Approval, Survival rate, Randomized Controlled Trials as Topic, Original Investigation, Clinical Trials as Topic, United States Food and Drug Administration, business.industry, Research, Health Policy, Hazard ratio, Cancer, General Medicine, medicine.disease, United States, 3. Good health, [SDV] Life Sciences [q-bio], Survival Rate, Clinical trial, Online Only, Treatment Outcome, Research Design, Hematologic Neoplasms, 030220 oncology & carcinogenesis, Relative risk, business

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::686767b8ec5f2942dfccdf2576ee7c83
https://doi.org/10.1001/jamanetworkopen.2020.24406